Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S M Albelda

Showing results (141-150 of 147) with videos related to

Pageof 15
Sort By:
You have reached the last page of results.This site can display upto 147 results.
The Annals of Thoracic Surgery|September 1, 1995
Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transferJ C Kucharczuk, A A Elshami, H B Zhang, et al.
Cancer Gene Therapy|July 1, 1997
The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoA A Elshami, J W Cook, K M Amin, et al.
Cancer Gene Therapy|August 27, 2011
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma modelsJ D Predina, B Judy, L A Aliperti, et al.
The American Journal of Pathology|September 1, 1997
Involvement of endothelial PECAM-1/CD31 in angiogenesisH M DeLisser, M Christofidou-Solomidou, R M Strieter, et al.
Cancer Gene Therapy|March 3, 2001
A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesotheliomaD H Sterman, K Molnar-Kimber, T Iyengar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitmentM T Nakada, K Amin, M Christofidou-Solomidou, et al.
Cancer Research|February 1, 1997
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesotheliomaJ C Kucharczuk, B Randazzo, M Y Chang, et al.
Pageof 15

Showing results (141-150 of 147) with videos related to

Sort By:
Pageof 15
You have reached the last page of results.This site can display upto 147 results.
The Annals of Thoracic Surgery|September 1, 1995
Pleural-based mesothelioma in immune competent rats: a model to study adenoviral gene transferJ C Kucharczuk, A A Elshami, H B Zhang, et al.
Cancer Gene Therapy|July 1, 1997
The effect of promoter strength in adenoviral vectors containing herpes simplex virus thymidine kinase on cancer gene therapy in vitro and in vivoA A Elshami, J W Cook, K M Amin, et al.
Cancer Gene Therapy|August 27, 2011
Neoadjuvant in situ gene-mediated cytotoxic immunotherapy improves postoperative outcomes in novel syngeneic esophageal carcinoma modelsJ D Predina, B Judy, L A Aliperti, et al.
The American Journal of Pathology|September 1, 1997
Involvement of endothelial PECAM-1/CD31 in angiogenesisH M DeLisser, M Christofidou-Solomidou, R M Strieter, et al.
Cancer Gene Therapy|March 3, 2001
A pilot study of systemic corticosteroid administration in conjunction with intrapleural adenoviral vector administration in patients with malignant pleural mesotheliomaD H Sterman, K Molnar-Kimber, T Iyengar, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 1999
Antibodies against the first Ig-like domain of human platelet endothelial cell adhesion molecule-1 (PECAM-1) that inhibit PECAM-1-dependent homophilic adhesion block in vivo neutrophil recruitmentM T Nakada, K Amin, M Christofidou-Solomidou, et al.
Cancer Research|February 1, 1997
Use of a "replication-restricted" herpes virus to treat experimental human malignant mesotheliomaJ C Kucharczuk, B Randazzo, M Y Chang, et al.
Pageof 15